Benefits of and barriers to the widespread use of spirometry

Current Opinion in Pulmonary Medicine

Volumn 11, Issue 2, 2005, Pages 115-120

  Petty, Thomas L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

COPD; Dyspnea; Economics; Smoking cessation; Spirometry

Indexed keywords

AGE DETERMINATION; AIRWAY OBSTRUCTION; ASTHMA; BLOOD PRESSURE; BLOOD VISCOSITY; BLOOD VOLUME; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DATA BASE; DEVICE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; ELECTROCARDIOGRAM; FORCED EXPIRATORY FLOW; HEALTH EDUCATION; HEALTH PROGRAM; HEART OUTPUT; HUMAN; LUNG FUNCTION; MEDICAL SCHOOL; MEDICAL SPECIALIST; MORTALITY; NITROGEN WASHOUT; PATIENT MONITORING; PHYSICIAN; PREDICTION; PRIMARY MEDICAL CARE; PROGNOSIS; QUALITY CONTROL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMALL AIRWAY DISEASE; SMOKING CESSATION; SMOKING HABIT; SPIROMETRY; THORAX PAIN; VASCULAR RESISTANCE; VITAL CAPACITY;

ADULT; AGED; EDUCATION, MEDICAL; HEALTH EDUCATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; PROFESSIONAL PRACTICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION; SPIROMETRY; UNITED STATES;

EID: 14044254792     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Hutchinson J: On the capacity of the lungs, and on the respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer. Med Chirurg Trans (Lond) 1846; 29:137-161.
2. Hogg JC, Macklem PT, Thurlbeck WM: Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-1360.
3. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298:1277-1281.
4. Buist AS, Van Fleet DL, Ross BB: A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis 1973; 107:735-743.
5. Dosman J, Bode F, Urbanetti J, et al. The use of helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers. J Clin Invest 1975; 55:1090-1099.
6. Woolcock AJ, Vincent NJ, Macklem PT: Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest 1969; 48:1097-1106.
7. 2 test identify the smoker who will develop chronic airflow limitation? Am Rev Respir Dis 1988; 137:293-301.
8. Stanescu DC, Rodenstein DO, Hoeven C, et al. "Sensitive tests" are poor predictors of the decline in forced expiratory volume on one second in middle-aged smokers. Am Rev Respir Dis 1987; 135:585-590.
9. Burrows B, Knudson R, Camilli A, et al. The "horse racing effect" and predicting decline in forced expiratory volume in 1 second from screening spirometry. Am Rev Respir Dis 1987; 135:788-793.
10. Morris JF, Temple W: Spirometric "lung age" estimation for motivating smoking cessation. Prev Med 1985; 14:655-662.
11. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128:491-500.
12. 1. The Lung Health Study. JAMA 1994; 272:1497-1505.
13. Petty TL, Weinmann GG: Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. JAMA 1997; 277:246-253.
14. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults. A consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146-1161.
15. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162:917-919.
16. Schoh RJ, Fero LJ, Shapiro H, et al. Performance of a new screening spirometer at a community health fair. Respir Care 2002; 47:1150-1157.
17. Enright PL, Carpo RO: Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in smokers. Clin Chest Med 2000; 21:645-652. A review of the controversies surrounding the widespread use of office spirometry.
18. Segnan N, Ponti A, Battista RN, et al. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control 1991; 2:239-246.
19. Zielinski J, Bevmarck M, et al. Early detection in a high risk population using spirometry screening. Chest 2001; 119:731-736.
20. Gorecka D, Bednarek M, Nowinski A, et al. Diagnosis of airflow limitation combined with smoking cessation advice increases stop smoking rates. Chest 2004; 123:1916-1923. This gives powerful evidence that spirometry can be useful in smoking cessation.
21. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice. The DIDASCO Study. Chest 2004; 125:1394-1399. A recent study shows the effectiveness of simple office spirometry in the diagnosis of COPD.
22. Van Schayck CP, Loozen JM, Wagena E, et al. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324:1370.
23. 1 and asbestos exposure. Eur Respir J 1998; 11:284-290.
24. Petty TL, Doherty DE: The National Lung Health Education Program: roots, mission, future directions. Respir Care 2004; 49:678-682. This gives the history of the National Lung Health Education Program.
25. Anderson S: Office spirometry: don't just blow it off. Med Econ 2004; 81:63-65. A detailed analysis of the costs and profits of a small clinic that established office spirometry as a standard office service.
26. Coding Consult: Emphysema and PFTs. Med Econ 2003; 80:9-20. This is a commentary on codes used for spirometry reimbursement.
27. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2002: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
28. Anders AJ, Baidwan B, Petty TL: An evaluation of the vitometer, a simple device for measuring vital capacity. Respir Care 1984; 29:1144-1146.
29. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.